-
Raloxifene, sold
under the
brand name
Evista among others, is a
medication used to
prevent and
treat osteoporosis in
postmenopausal women and
those on...
-
antiestrogenic activity.
Raloxifene is a SERM that is more
antiestrogenic than tamoxifen; both are
estrogenic in bone, but
raloxifene is
antiestrogenic in...
- Estradiol/
raloxifene (E2/RLX) is a tissue-selective
estrogen complex (TSEC)
which was
studied for
potential use in
menopausal hormone therapy but was never...
-
recommended for 10 years. In 2006, the
large STAR
clinical study concluded that
raloxifene is also
effective in
reducing the
incidence of
breast cancer. Updated...
- with the
selective estrogen receptor modulators (SERMs)
tamoxifen and
raloxifene. The
phenomenon indicates that
these agents can
somehow result in stimulation...
- coagulation, in
contrast to
estrogens and
other SERMs like
tamoxifen and
raloxifene. A
binding ****ay was also
performed to
measure the
affinity of ospemifene...
-
Intravenous (IV) iron
sucrose Conjugated estrogens Teriparatide Naproxen Raloxifene Long
acting adrenergic beta-agonists (LABAs) Hydroxymethylglutaryl-coenzyme...
-
significantly higher than
reductions found with the
related SERMs tamoxifen and
raloxifene. In accordance, a
network meta-analysis of
SERMs for
breast cancer prevention...
- miroestrol)
Selective estrogen receptor modulators (e.g., tamoxifen, clomifene,
raloxifene)
Antiestrogens (e.g., fulvestrant, ICI-164384, ethamoxytriphetol) The...
- not
increase the risk of
breast cancer. Jordan's
paper The
Effect of
Raloxifene on Risk of
Breast Cancer in
Postmenopausal Women:
Results from the More...
